Back to dashboard
Medicare AdvantageCoverageMedium impact

MA05.005g, Automatic External Cardioverter Defibrillators (Wearable and Nonwearable)

Independence Blue Cross·Cardiology, Internal Medicine, Family Medicine +2 more·Medical Policy
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Days to comply

Summary

Medicare Advantage policy MA05.005g for Automatic External Cardioverter Defibrillators (both wearable and non-wearable devices) has been reissued and will take effect April 2, 2025. This policy update may affect coverage criteria, billing requirements, or documentation standards for these life-saving cardiac devices.

Action Required

Action needed
By April 2, 2025: Billing team must review the full MA05.005g policy at the source URL to identify specific changes to coverage criteria, billing requirements, or documentation standards for wearable and non-wearable cardioverter defibrillators. Update billing protocols and staff training accordingly based on the detailed policy content.